| Page 1959 | Kisaco Research
 

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult
 

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix

Mark Aspinall O’Dea

EMEA Business Development Manager
Retogenix
 
AH Europe 2019
26-27 Feb 2019
200 Aldersgate, St. Pauls, London, UK
Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners. To complement our investment pitches, we host CEO-level discussions that address the trends and market dynamics of the animal health industry, across all species. A key element of the investment forum is the full use of a our 1-on-1 private meeting platform, available to all attendees. Going forward, as the industry experiences a shift towards the detection and prevention of disease, we are increasingly focused on presenting innovation in nutritional health, data analytics, sensors and diagnostics.This year, for the first time, we will be categorising our presenting companies according to the level of investment they’re seeking, early, mid and late stage.
Visit Site
Agenda from Human Biotech & Animal Health USA 2018
 
Human Biotech Animal Health EU
18-19 Jun 2018
Amsterdam, The Netherlands
Join the first ever conference series connecting human biotechs with the animal health industry. Following the event's hugely successful launch in Boston, USA, Human Biotech & Animal Health Business Partnering Summit is now coming to Europe. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
Visit Site
 

Josh Goldin

Alliance Consumer Growth

Josh Goldin

Alliance Consumer Growth

Josh Goldin

Alliance Consumer Growth
 

David Beno

Chief Scientific Officer
Xeno Biosciences

David Beno

Chief Scientific Officer
Xeno Biosciences

David Beno

Chief Scientific Officer
Xeno Biosciences
Microbiome Event Series Calendar
 

Ava Firth

Director of R&D
Tonisity

Ava is a veterinarian and board-certified specialist in veterinary emergency and critical care. Originally from Ohio, USA, she has held both private practice and university positions in the USA, Australia and the United Kingdom, specialising in small animal emergencies and lecturing internationally.

Read full bio

Ava Firth

Director of R&D
Tonisity

Ava Firth

Director of R&D
Tonisity

Ava is a veterinarian and board-certified specialist in veterinary emergency and critical care. Originally from Ohio, USA, she has held both private practice and university positions in the USA, Australia and the United Kingdom, specialising in small animal emergencies and lecturing internationally.

Her interest in critical care nutrition, particularly microenteral nutrition, led to her position as Director of Research and Development for Tonisity. She is responsible for designing and coordinating research and trials, as well as managing the product development pipeline and regulatory affairs.